CTI BioPharma Corp.
CTIC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $689,311 | $223,490 | $229,074 | $91,599 |
| - Cash | $30,420 | $65,446 | $40,394 | $31,144 |
| + Debt | $49,958 | $50,556 | $5,255 | $12,260 |
| Enterprise Value | $708,849 | $208,600 | $193,935 | $72,715 |
| Revenue | $53,948 | $0 | $0 | $3,345 |
| % Growth | – | – | -100% | – |
| Gross Profit | $50,434 | -$161 | -$4,200 | $3,345 |
| % Margin | 93.5% | – | – | 100% |
| EBITDA | -$79,853 | -$95,332 | -$51,215 | -$37,425 |
| % Margin | -148% | – | – | -1,118.8% |
| Net Income | -$91,041 | -$99,636 | -$52,951 | -$42,317 |
| % Margin | -168.8% | – | – | -1,265.1% |
| EPS Diluted | -0.79 | -1.11 | -0.74 | -0.73 |
| % Growth | 28.8% | -50% | -1.4% | – |
| Operating Cash Flow | -$81,194 | -$84,889 | -$42,205 | -$27,822 |
| Capital Expenditures | -$25,000 | $0 | -$17 | $0 |
| Free Cash Flow | -$106,194 | -$84,889 | -$42,222 | -$27,822 |